Increased Radial Force Improves Stent Deployment in Tricuspid but Not in Bicuspid Stenotic Native Aortic Valves

Annals of Thoracic Surgery

Volumn 89, Issue 3, 2010, Pages 768-772

  Zegdi, Rachid ^a,b,c   Lecuyer, Lucien ^a,b   Achouh, Paul ^b   Didier, Blanchard ^b   Lafont, Antoine ^b   Latrémouille, Christian ^a,b   Fabiani, Jean Noël ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA PROSTHESIS; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BICUSPID AORTIC VALVE; BIOPROSTHESIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PRIORITY JOURNAL; STENT; TRICUSPID AORTIC VALVE; TRICUSPID VALVE;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOMECHANICS; FEMALE; HUMANS; MALE; MIDDLE AGED; STENTS;

EID: 76749129375     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.12.022     Document Type: Article

References (12)

1. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Circulation 48 (2006) e1-e148
2. Cribier A., Eltchaninoff H., Tron C., et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 43 (2004) 698-703
3. Grube E., Laborde J.C., Gerckens U., et al. Percutaneous implantation of the Corevalve self-expanding valve prosthesis in high-risk patients with aortic valve disease. The Siegburg first-in-man study. Circulation 114 (2006) 1616-1624
4. Webb J.G., Chandavimol M., Thompson C.R., et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113 (2006) 842-850
5. Vassiliades T.A., Block P.C., Cohn L.H., et al. The clinical development of percutaneous heart valve technology. A position statement of the society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Intervention (SCAI). J Thorac Cardiovasc Surg 129 (2005) 970-976
6. Zegdi R., Ciobotaru V., Noghin M., et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent?. Results from a human anatomic study in adults. J Am Coll Cardiol 51 (2008) 579-584
7. Roberts W.C., and Ko J.M. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111 (2005) 920-925
8. Van Nooten G., Ozaki S., Herijgers P., Segers P., Verdonck P., and Flameng W. Distortion of the stentless porcine valve induces accelerated leaflet fibrosis and calcification in juvenile sheep. J Heart Valve Dis 8 (1999) 34-41
9. Willems T.P., Herwerden L.V., Taams M.A., Kleyburg-Linker V.E., Roelandt J.C., and Egbert B. Aortic allograft implantation techniques: pathomorphology and regurgitant jet patterns by Doppler echocardiographic studies. Ann Thorac Surg 66 (1998) 412-416
10. Athanasiou T., Jones C., Jin R., Grunkemeier G.L., and Ross D.N. Homograft implantation techniques in the aortic position: to preserve or replace the aortic root?. Ann Thorac Surg 81 (2006) 1578-1586
11. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous trancatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. First human case description. Circulation 106 (2002) 3006-3008
12. Zegdi R., Khabbaz Z., Borenstein N., and Fabiani J.N. A repositionable valved stent for endovascular treatment of deteriorated bioprostheses. J Am Coll Cardiol 48 (2006) 1365-1368